1. Gilead may be looking to buy oncology startup Forty-Seven —FDA announces that COVID-19 has caused its first US drug shortage — Passage Bio raises upsized $216M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Interview feedback?

Discussion in 'Alkermes' started by anonymous, Jan 18, 2020 at 10:56 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I interviewed for a position in Waltham for 5461. Is it for sure not happening? They promised it was going to be a blockbuster drug. I am really pretty and have an amazing personality and believe I would be a true asset to the company. I am going to call the HR person next week to find out what is happening with my job offer. Bye everyone! See you soon! ❤️
     

  2. anonymous

    anonymous Guest

    Offers going out on Tuesday! Good luck
     
  3. anonymous

    anonymous Guest

    Yes an offer coming for a model job... a foot model for Payless shoes. Good luck
     
  4. anonymous

    anonymous Guest

    Attempted humor! Fail!!
     
  5. anonymous

    anonymous Guest

    Hey guys, it’s me again. I waited until Tuesday last week like you said and still no offer letter or call back. I really want to sell 5461 and turn help turn this company around. Like I said, I am really pretty, I have long straight hair, I do yoga five days a week and I dress to impress. Why wouldn’t you hire me? Love you all. ❤️❤️❤️
     
  6. anonymous

    anonymous Guest

    Another attempt and another big fail
     
  7. anonymous

    anonymous Guest

    ALKS filed a petition yet again with FDA that 5461 works and patients are waiting - asked FDA to reconsider its mistake in evaluating 5461 efficacy and approve it as soon as possible along with 3831 - both have ALKS secret sauce with MOA needed. LOL
     
  8. anonymous

    anonymous Guest

    MOA not needed as it’s an ALKS sauce that can be added to any approved drug to have a new drug formulation
     
  9. anonymous

    anonymous Guest

    Have no fear we have a robust pipeline. Just look at all the products we are coming out with. I'll list them for all you pathetic losers and Alkermes haters.

    ALKS3832 - Asprin and Samidorphan; think they are going to call it "Asimda"
    ALKS3833 - table salt and Samidorphan; calling that one "doesnothingaphan"
    ALKS3834 - jello and Samidorphan; no name yet - maybe they can have an internal naming contest for it?
    ALKS3835 - dog crap and Samidorphan; naming this on "basically every product ALKS has put forward since Vivitrol"
    ALKS3831 = Olanzapine and Samidorphan; this one is being named "launch flopizole"

    So next time you haters start hating, make sure you have all the facts!